Brief: Checkpoint Therapeutics Reports Q2 2022 Results
12/08/2022 13:27
Aug 12 (Reuters) - Checkpoint Therapeutics Inc CKPT.O :
* CHECKPOINT THERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND RECENT CORPORATE HIGHLIGHTS
* CHECKPOINT THERAPEUTICS INC - AS OF JUNE 30, 2022, CO'S
CASH AND
CASH EQUIVALENTS TOTALED $30.9 MILLION
* CHECKPOINT THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.16
* CHECKPOINT THERAPEUTICS INC - DISCONTINUING ITS CONTERNO
STUDY
Source text for Eikon: ID:nGNX7YBCBW
Further company coverage: CKPT.O
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say